Compliance with biopsy recommendations of a prostate cancer risk calculator
BJU International, 05/07/2012van Vugt HA et al.
Recommendations of the European Randomized study of Screening for Prostate Cancer risk calculator (RC) on prostate biopsy were followed in most patients. The RC hence may be a promising tool for supporting clinical decision–making.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.